Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 14 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG

    Scottsdale/Phoenix, AZ

  2. Pivotal 2 Study Of RGX-314 Gene Therapy In Participants With NAMD

    Rochester, MN

  3. A Study Of SGT-501 Gene Therapy In Catecholaminergic Polymorphic Ventricular Tachycardia

    Rochester, MN

  4. Gene Therapy For HER-Positive Cancer (SENTRY-HER2)

    Jacksonville, FL, Rochester, MN

  5. A Phase 1 AAV Gene Therapy Trial Evaluating Safety And Preliminary Efficacy Of RP-A701 In Subjects With BAG3 Dilated Cardiomyopathy

    Rochester, MN

  6. Long-Term Follow-up Protocol For Participants Treated With Gene-Modified T Cells

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate Gene Therapy For Propionic Acidemia Patients

    Rochester, MN

  8. Anti-VEGF Gene Therapy Trial For Vestibular Schwannoma

    Rochester, MN

  9. AMT-260 Gene Therapy Study In Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. A Phase 1/2/3 Study Of ATSN-201 Gene Therapy In Subjects With RS1-Associated X-linked Retinoschisis

    Rochester, MN

.

Mayo Clinic Footer